858 related articles for article (PubMed ID: 25229996)
1. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
3. Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark.
Miller IM; Vindsand Naver A; Mogensen UB; Zarchi K; Ring HC; Ellervik C; Jemec GB
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1392-8. PubMed ID: 26426833
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.
Shalom G; Freud T; Harman-Boehm I; Polishchuk I; Cohen AD
Br J Dermatol; 2015 Aug; 173(2):464-70. PubMed ID: 25760289
[TBL] [Abstract][Full Text] [Related]
5. Systemic associations of hidradenitis suppurativa.
Kohorst JJ; Kimball AB; Davis MD
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
[TBL] [Abstract][Full Text] [Related]
6. Endocrinologic Aspects of Hidradenitis Suppurativa.
Karagiannidis I; Nikolakis G; Zouboulis CC
Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
Tzellos T; Zouboulis CC; Gulliver W; Cohen AD; Wolkenstein P; Jemec GB
Br J Dermatol; 2015 Nov; 173(5):1142-55. PubMed ID: 26153913
[TBL] [Abstract][Full Text] [Related]
8. A Population- and Hospital-based Cross-sectional Study of Renal Function in Hidradenitis Suppurativa.
Miller IM; Carlson N; Mogensen UB; Ellervik C; Jemec GB
Acta Derm Venereol; 2016 Jan; 96(1):68-71. PubMed ID: 25710874
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan.
Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
J Dermatol; 2019 Oct; 46(10):867-873. PubMed ID: 31389066
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases.
Miller IM; Ring HC; Prens EP; Rytgaard H; Mogensen UB; Ellervik C; Jemec GB
Dermatology; 2016; 232(4):511-9. PubMed ID: 27287331
[TBL] [Abstract][Full Text] [Related]
11. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
12. Body composition and basal metabolic rate in Hidradenitis Suppurativa: a Danish population-based and hospital-based cross-sectional study.
Miller IM; Rytgaard H; Mogensen UB; Miller E; Ring HC; Ellervik C; Jemec GB
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):980-8. PubMed ID: 26660945
[TBL] [Abstract][Full Text] [Related]
13. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa.
Miller IM; McAndrew RJ; Hamzavi I
Dermatol Clin; 2016 Jan; 34(1):7-16. PubMed ID: 26617352
[TBL] [Abstract][Full Text] [Related]
17. Coagulation Status in Hidradenitis Suppurativa: A Danish Population- and Hospital-Based Cross-Sectional Study.
Miller IM; Johansen ME; Mogensen UB; Zarchi K; Ellervik C; Jemec GB
Dermatology; 2015; 231(2):119-26. PubMed ID: 26138620
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
19. Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Garg A
JAMA Dermatol; 2019 Jul; 155(7):797-802. PubMed ID: 30994865
[TBL] [Abstract][Full Text] [Related]
20. Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa.
Shalom G; Babaev M; Freud T; Tiosano S; Pam N; Horev A; Dreiher J; Vardy DA; Comaneshter D; Cohen AD
J Am Acad Dermatol; 2017 Dec; 77(6):1047-1052.e2. PubMed ID: 28989106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
